Judith Johnson - Concepedia

Concepedia

Author

Judith Johnson

Idera Pharmaceuticals (United States)

Also Known As

J Johnson, Judith B. Johnson, Judith Johnson

15

Publications

1.1K

Citations

8

H-Index

17

Concepts

All Affiliations

Idera Pharmaceuticals (United States)Sterling Research Group University of Pennsylvania South Australian Health and Medical Research Institute Medpace (United States)

JJ

About

Judith Johnson is an author at Idera Pharmaceuticals (United States) specializing in pharmacology, medicine, and metabolism.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	738
2	Health Sciences	1	1	609
3	Biochemistry	1	1	609
4	Diabetes	1	1	105
5	Gastroenterology	1	1	609

Judith Johnson

×

8

Publications

1.1K

Citations

8

H-Index

	Year	Citations
Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins Daniel V. Kimberg, Michael Field, Judith Johnson, Journal of Clinical Investigation Cholera EnterotoxinGastroenterologyPathologyDigestive TractGastrointestinal Peptide Hormone	1971	609
A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) study Michael Davidson, Judith Johnson, Michael W. Rooney, Journal of clinical lipidology NutritionOmega-3 Fatty AcidLipid NutritionOmega-3-acid Ethyl EstersPharmacology	2012	185
A Highly Bioavailable Omega-3 Free Fatty Acid Formulation Improves the Cardiovascular Risk Profile in High-Risk, Statin-Treated Patients With Residual Hypertriglyceridemia (the ESPRIT Trial) Kevin C. Maki, David G. Orloff, Stephen J. Nicholls, Clinical Therapeutics Metabolic SyndromeCardiovascular DiseaseOmega-3 Fatty AcidMedicineDiabetes	2013	105
Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study Elliot Offman, Ted Marenco, Sandy Ferber, Vascular Health and Risk Management	2013	89
Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial Richard L. Dunbar, Stephen J. Nicholls, Kevin C. Maki, Lipids in Health and Disease	2015	53
Effect of omega-3-acid ethyl esters on the steady-state plasma pharmacokinetics of rosuvastatin in healthy adults Pritti Gosai, Jianhua Liu, Ralph T. Doyle, Expert Opinion on Pharmacotherapy	2008	25
Omega-3 Free Fatty Acids Demonstrate More Than 4-Fold Greater Bioavailability for EPA and DHA Compared with Omega-3-acid Ethyl Esters in Conjunction with a Low-Fat Diet: The ECLIPSE Study † Douglas Kling, Judith Johnson, Michael W. Rooney, Journal of clinical lipidology NutritionOmega-3 Fatty AcidMedicineOmega-3-acid Ethyl EstersLipid Nutrition	2011	24
Effect of omega-3-acid ethyl esters on steady-state plasma pharmacokinetics of atorvastatin in healthy adults Mike Di Spirito, G Morelli, Doyle Rt, Expert Opinion on Pharmacotherapy	2008	18

Page 1